Advertisement
Screener

GALECTIN THERAPEUTICS INC. (GALT) Form D

GALECTIN THERAPEUTICS INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2017-01-06: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2016-12-22; Total offering amount $10,000,000.
  • 2016-09-28: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2016-09-22; Total offering amount $12,000,000.
  • 2015-12-21: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2015-11-25; Total offering amount Indefinite.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2017-01-06Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2016-12-22$10,000,000$3,000,000$7,000,0005
2016-09-28Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2016-09-22$12,000,000$1,500,000$10,500,0001
2015-12-21Rule 506(b)OptionToAcquire; SecurityToBeAcquired2015-11-25Indefinite$0Indefinite6

Similar stocks

Stock NameCountryMarket CapPE Ratio
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Rezolute, Inc. (RZLT)United States$0.382B-6.45
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63